1. Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment
   Ewelina Dratkiewicz et al, 2019, IJMS CrossRef
2. Screening and Interaction Analysis of Key Genes in miR-542-3p Over- Expressed Osteosarcoma Cells by Bioinformatics
   Zhongqiu Li et al, 2020, CCHTS CrossRef
3. Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies
   Ingrid Lilienthal et al, 2020, IJMS CrossRef
4. Cellular plasticity and drug resistance in sarcoma
   Zhengjun Lin et al, 2020, Life Sciences CrossRef
5. Targeting the Hippo Pathway in Prostate Cancer: What’s New?
   Kelly Coffey, 2021, Cancers CrossRef
6. Mechanisms of Resistance to Conventional Therapies for Osteosarcoma
   Louise Marchandet et al, 2021, Cancers CrossRef
7. MiR-506 exerts antineoplastic effects on osteosarcoma cells via inhibition of the Skp2 oncoprotein
   Lu Ding et al, 2021, Aging CrossRef
8. Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition.
   Jingjing Sha et al, 2021, Biomolecules CrossRef
9. LncRNA SCAMP1 disrupts the balance between miR-26a-5p and ZEB2 to promote osteosarcoma cell viability and invasion
   Rong Li et al, 2022, Front. Oncol. CrossRef
10. Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance.
    Maja Sabol, 0 CrossRef
11. LncRNA HOXA-AS3 promotes cell proliferation and invasion via targeting miR-218-5p/FOXP1 axis in osteosarcoma
    Rong Li et al, 2024, Sci Rep CrossRef
12. Single-cell RNA sequencing reveals the communications between tumor microenvironment components and tumor metastasis in osteosarcoma
    Jiatong Li et al, 2024, Front. Immunol. CrossRef